Platelet microparticles: Detection and assessment of their paradoxical functional roles in disease and regenerative medicine

Blood Reviews

Volumn 28, Issue 4, 2014, Pages 155-166

  Burnouf, Thierry ^a   Goubran, Hadi Alphonse ^b   Chou, Ming Li ^c   Devos, David ^d   Radosevic, Mirjana ^e  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d UNIV LILLE   (France)

^e HUMAN PROTEIN PROCESS SCIENCES   (France)

Author keywords

Blood transfusion; Detection; Microparticles; Pathology; Platelets; Regenerative medicine

Indexed keywords

PHOSPHATIDYLSERINE; PHOSPHOLIPID; THROMBOCYTE RECEPTOR; BIOLOGICAL MARKER;

APOPTOSIS; ATHEROSCLEROSIS; ATOMIC FORCE MICROSCOPY; CELL ASSAY; CELL COMMUNICATION; CELL ISOLATION; CELL MEMBRANE; CELL SIZE; CELL STRESS; CELL STRUCTURE; FLOW CYTOMETRY; HEMOSTASIS; HUMAN; INFLAMMATION; LIGHT SCATTERING; NEOPLASM; PLATELET MICROPARTICLE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN STRUCTURE; PROTEOMICS; REGENERATIVE MEDICINE; REVIEW; THROMBOCYTE ACTIVATION; THROMBOCYTE FUNCTION; THROMBOSIS; TISSUE REGENERATION; VASCULARIZATION; ANIMAL; CHEMISTRY; MEMBRANE MICROPARTICLE; METABOLISM; THROMBOCYTE;

ANIMALS; BIOLOGICAL MARKERS; BLOOD PLATELETS; CELL-DERIVED MICROPARTICLES; HUMANS; REGENERATIVE MEDICINE;

EID: 84903150116     PISSN: 0268960X     EISSN: 15321681     Source Type: Journal    
DOI: 10.1016/j.blre.2014.04.002     Document Type: Article

References (157)

1. van der Pol E., Boing A.N., Harrison P., Sturk A., Nieuwland R. Classification, functions, and clinical relevance of extracellular vesicles. Pharmacol Rev 2012, 64:676-705.
2. Yuana Y., Sturk A., Nieuwland R. Extracellular vesicles in physiological and pathological conditions. Blood Rev 2013, 27:31-39.
3. Hoyer F.F., Nickenig G., Werner N. Microparticles-messengers of biological information. J Cell Mol Med 2010, 14:2250-2256.
4. VanWijk M.J., VanBavel E., Sturk A., Nieuwland R. Microparticles in cardiovascular diseases. Cardiovasc Res 2003, 59:277-287.
5. Zwaal R.F.A., Comfurius P., Bevers E.M. Surface exposure of phosphatidylserine in pathological cells. Cell Mol Life Sci 2005, 62:971-988.
6. Hugel B., Carmen M., Martinez M.C., Kunzelmann C., Freyssinet J.M. Membrane microparticles: two sides of the coin. Physiology 2005, 20:22-27.
7. Wolf P. The nature and significance of platelet products in human plasma. Br J Haematol 1967, 13:269-288.
8. Lynch S.F., Ludlam C.A. Plasma microparticles and vascular disorders. Br J Haematol 2007, 137:36-48.
9. Simak J., Gelderman M.P. Cell membrane microparticles in blood and blood products: potentially pathogenic agents and diagnostic markers. Transfus Med Rev 2006, 20:1-26.
10. Siljander P.R.M. Platelet-derived microparticles-an updated perspective. Thromb Res 2011, 127:S30-S33.
11. Piccin A., Murphy W.G., Smith O.P. Circulating microparticles: pathophysiology and clinical implications. Blood Rev 2007, 21:157-171.
12. Baj-Krzyworzeka M., Majka M., Pratico D., Ratajczak J., Vilaire G., Kijowski J., et al. Platelet-derived microparticles stimulate proliferation, survival, adhesion, and chemotaxis of hematopoietic cells. Exp Hematol 2002, 30:450-459.
13. Delabranche X., Berger A., Boisramé-Helms J., Meziani F. Microparticles and infectious diseases. Med Mal Infect 2012, 42:335-343.
14. Harrison P., Cramer E.M. Platelet alpha-granules. Blood Rev 1993, 7:52-62.
15. Laffont B., Corduan A., Ple H., Duchez A.-C., Cloutier N., Boilard E., et al. Activated platelets can deliver mRNA regulatory Ago2.microRNA complexes to endothelial cells via microparticles. Blood 2013, 122:253-261.
16. Saas P., Angelot F., Bardiaux L., Seilles E., Garnache-Ottou F., Perruche S. Phosphatidylserine-expressing cell by-products in transfusion: a pro-inflammatory or an anti-inflammatory effect?. Transfus Clin Biol 2012, 19:90-97.
17. Morel O., Morel N., Freyssinet J.M., Toti F. Platelet microparticles and vascular cells interactions: a checkpoint between the haemostatic and thrombotic responses. Platelets 2008, 19:9-23.
18. Momen-Heravi F., Balaj L., Alian S., Tigges J., Toxavidis V., Ericsson M., et al. Alternative methods for characterization of extracellular vesicles. Front Physiol 2012, 3:354.
19. Gyorgy B., Szabo T.G., Turiak L., Wright M., Herczeg P., Ledeczi Z., et al. Improved flow cytometric assessment reveals distinct microvesicle (cell-derived microparticle) signatures in joint diseases. PLoS One 2012, 7.
20. Ayers L., Kohler M., Harrison P., Sargent I., Dragovic R., Schaap M., et al. Measurement of circulating cell-derived microparticles by flow cytometry: sources of variability within the assay. Thromb Res 2011, 127:370-377.
21. Artoni A., Merati G., Padovan L., Scalambrino E., Chantarangkul V., Tripodi A. Residual platelets are the main determinants of microparticles count in frozen-thawed plasma. Thromb Res 2012, 130:561-562.
22. Lacroix R., Judicone C., Poncelet P., Robert S., Arnaud L., Sampol J., et al. Impact of pre-analytical parameters on the measurement of circulating microparticles: towards standardization of protocol. J Thromb Haemost 2012, 10:437-446.
23. Freyssinet J.M., Dignat-George F. More on: measuring circulating cell-derived microparticles. J Thromb Haemost 2005, 3:613-614.
24. Jy W., Horstman L.L., Jimenez J.J., Ahn Y.S. Measuring circulating cell-derived microparticles. J Thromb Haemost 2004, 2:1842-1851.
25. Cocucci E., Racchetti G., Meldolesi J. Shedding microvesicles: artefacts no more. Trends Cell Biol 2009, 19:43-51.
26. Kalra H., Simpson R.J., Ji H., Aikawa E., Altevogt P., Askenase P., et al. Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation. PLoS Biol 2012, 10:e1001450.
27. Mathivanan S., Ji H., Simpson R.J. Exosomes: extracellular organelles important in intercellular communication. J Proteomics 2010, 73:1907-1920.
28. Abrams C.S., Ellison N., Budzynski A.Z., Shattil S.J. Direct detection of activated platelets and platelet-derived microparticles in humans. Blood 1990, 75:128-138.
29. Christersson C., Johnell M., Siegbahn A. Evaluation of microparticles in whole blood by multicolour flow cytometry assay. Scand J Clin Lab Invest 2013, 73:229-239.
30. Lacroix R., Robert S., Poncelet P., Kasthuri R.S., Key N.S., Dignat-George F., et al. Standardization of platelet-derived microparticle enumeration by flow cytometry with calibrated beads: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop. J Thromb Haemost 2010, 8:2571-2574.
31. Robert S., Poncelet P., Lacroix R., Arnaud L., Giraudo L., Hauchard A., et al. Standardization of platelet-derived microparticle counting using calibrated beads and a Cytomics FC500 routine flow cytometer: a first step towards multicenter studies?. J Thromb Haemost 2009, 7:190-197.
32. Yuana Y., Oosterkamp T.H., Bahatyrova S., Ashcroft B., Rodriguez P.G., Bertina R.M., et al. Atomic force microscopy: a novel approach to the detection of nanosized blood microparticles. J Thromb Haemost 2010, 8:315-323.
33. Zwicker J.I., Lacroix R., Dignat-George F., Furie B.C., Furie B. Measurement of platelet microparticles. Methods Mol Biol 2012, 788:127-139.
34. Mobarrez F., Nybom R., Johansson V., Hultman C.M., Wallen H., Landen M., et al. Microparticles and microscopic structures in three fractions of fresh cerebrospinal fluid in schizophrenia: case report of twins. Schizophr Res 2013, 143:192-197.
35. Parot P., Dufrene Y.F., Hinterdorfer P., Le Grimellee C., Navajas D., Pellequer J.L., et al. Past, present and future of atomic force microscopy in life sciences and medicine. J Mol Recognit 2007, 20:418-431.
36. Leong H.S., Podor T.J., Manocha B., Lewis J.D. Validation of flow cytometric detection of platelet microparticles and liposomes by atomic force microscopy. J Thromb Haemost 2011, 9:2466-2476.
37. Lawrie A.S., Albanyan A., Cardigan R.A., Mackie I.J., Harrison P. Microparticle sizing by dynamic light scattering in fresh-frozen plasma. Vox Sang 2009, 96:206-212.
38. Xu Y., Nakane N., Maurer-Spurej E. Novel test for microparticles in platelet-rich plasma and platelet concentrates using dynamic light scattering. Transfusion 2011, 51:363-370.
39. Dragovic R.A., Gardiner C., Brooks A.S., Tannetta D.S., Ferguson D.J., Hole P., et al. Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis. Nanomed Nanotechnol Biol Med 2011, 7:780-788.
40. Filipe V., Hawe A., Jiskoot W. Critical evaluation of Nanoparticle Tracking Analysis (NTA) by NanoSight for the measurement of nanoparticles and protein aggregates. Pharm Res 2010, 27:796-810.
41. Platt M., Willmott G.R., Lee G.U. Resistive pulse sensing of analyte-induced multicomponent rod aggregation using tunable pores. Small 2012, 8:2436-2444.
42. Anderson W., Kozak D., Coleman V.A., Jamting A.K., Trau M. A comparative study of submicron particle sizing platforms: accuracy, precision and resolution analysis of polydisperse particle size distributions. J Colloid Interface Sci 2013, 405:322-330.
43. Connor D.E., Exner T., Ma D.D., Joseph J.E. The majority of circulating platelet-derived microparticles fail to bind annexin V, lack phospholipid-dependent procoagulant activity and demonstrate greater expression of glycoprotein Ib. Thromb Haemost 2010, 103:1044-1052.
44. Enjeti A.K., Lincz L.F., Seldon M. Detection and measurement of microparticles: an evolving research tool for vascular biology. Semin Thromb Hemost 2007, 33:771-779.
45. Hellum M., Ovstebo R., Troseid A.M.S., Berg J.P., Brandtzaeg P., Henriksson C.E. Microparticle-associated tissue factor activity measured with the Zymuphen MP-TF kit and the calibrated automated thrombogram assay. Blood Coagul Fibrinolysis 2012, 23:520-526.
46. Wang J.G., Manly D., Kirchhofer D., Pawlinski R., Mackman N. Levels of microparticle tissue factor activity correlate with coagulation activation in endotoxemic mice. J Thromb Haemost 2009, 7:1092-1098.
47. Lacroix R., Dubois C., Leroyer A.S., Sabatier F., Dignat-George F. Revisited role of microparticles in arterial and venous thrombosis. J Thromb Haemost 2013, 11:24-35.
48. Aras O., Shet A., Bach R.R., Hysjulien J.L., Slungaard A., Hebbel R.P., et al. Induction of microparticle- and cell-associated intravascular tissue factor in human endotoxemia. Blood 2004, 103:4545-4553.
49. Hemker H.C., Giesen P., AlDieri R., Regnault V., de Smed E., Wagenvoord R., et al. The calibrated automated thrombogram (CAT): a universal routine test for hyper- and hypocoagulability. Pathophysiol Haemost Thromb 2002, 32:249-253.
50. Osumi K., Ozeki Y., Saito S., Nagamura Y., Ito H., Kimura Y., et al. Development and assessment of enzyme immunoassay for platelet-derived microparticles. Thromb Haemost 2001, 85:326-330.
51. Nomura S., Shouzu A., Taomoto K., Togane Y., Goto S., Ozaki Y., et al. Assessment of an ELISA kit for platelet-derived microparticles by joint research at many institutes in Japan. J Atheroscler Thromb 2009, 16:878-887.
52. Watts J.A., Lee Y.Y., Gellar M.A., Fulkerson M.B.K., Hwang S.I., Kline J.A. Proteomics of microparticles after experimental pulmonary embolism. Thromb Res 2012, 130:122-128.
53. Capriotti A.L., Caruso G., Cavaliere C., Piovesana S., Samperi R., Lagana A. Proteomic characterization of human platelet-derived microparticles. Anal Chim Acta 2013, 776:57-63.
54. Shai E., Rosa I., Parguina A.F., Motahedeh S., Varon D., Garcia A. Comparative analysis of platelet-derived microparticles reveals differences in their amount and proteome depending on the platelet stimulus. J Proteomics 2012, 76:287-296.
55. Garcia B.A., Smalley D.M., Cho H., Shabanowitz J., Ley K., Hunt D.F. The platelet microparticle proteome. J Proteome Res 2005, 4:1516-1521.
56. Smalley D.M., Root K.E., Cho H.J., Ross M.M., Ley K. Proteomic discovery of 21 proteins expressed in human plasma-derived but not platelet-derived microparticles. Thromb Haemost 2007, 97:67-80.
57. Ramacciotti E., Hawley A.E., Wrobleski S.K., Myers D.D., Strahler J.R., Andrews P.C., et al. Proteomics of microparticles after deep venous thrombosis. Thromb Res 2010, 125:E269-E274.
58. Leroyer A.S., Tedgui A., Boulanger C.M. Role of microparticles in atherothrombosis. J Intern Med 2008, 263:528-537.
59. Terrisse A.D., Puech N., Allart S., Gourdy P., Xuereb J.M., Payrastre B., et al. Internalization of microparticles by endothelial cells promotes platelet/endothelial cell interaction under flow. J Thromb Haemost 2010, 8:2810-2819.
60. Ohtsuka M., Sasaki K., Ueno T., Seki R., Nakayoshi T., Koiwaya H., et al. Platelet-derived microparticles augment the adhesion and neovascularization capacities of circulating angiogenic cells obtained from atherosclerotic patients. Atherosclerosis 2013, 227:275-282.
61. Suades R., Padro T., Vilahur G., Badimon L. Circulating and platelet-derived microparticles in human blood enhance thrombosis on atherosclerotic plaques. Thromb Haemost 2012, 108:1208-1219.
62. Freyssinet J.M. Cellular microparticles: what are they bad or good for?. J Thromb Haemost 2003, 1:1655-1662.
63. Shai E., Rosa I., Parguina A.F., Motahedeh S., Varon D., Garcia A. Comparative analysis of platelet-derived microparticles reveals differences in their amount and proteome depending on the platelet stimulus. J Proteomics 2012, 76. [Spec No.:287-96].
64. Varon D., Shai E. Role of platelet-derived microparticles in angiogenesis and tumor progression. Discov Med 2009, 8:237-241.
65. Burger D., Schock S., Thompson C.S., Montezano A.C., Hakim A.M., Touyz R.M. Microparticles: biomarkers and beyond. Clin Sci 2013, 124:423-441.
66. Shantsila E., Kamphuisen P.W., Lip G.Y. Circulating microparticles in cardiovascular disease: implications for atherogenesis and atherothrombosis. J Thromb Haemost 2010, 8:2358-2368.
67. Owens A.P., Mackman N. Microparticles in hemostasis and thrombosis. Circ Res 2011, 108:1284-1297.
68. Italiano J.E., Mairuhu A.T.A., Flaumenhaft R. Clinical relevance of microparticles from platelets and megakaryocytes. Curr Opin Hematol 2010, 17:578-584.
69. Berckmans R.J., Nieuwland R., Boing A.N., Romijn F.P., Hack C.E., Sturk A. Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost 2001, 85:639-646.
70. Boulanger C.M., Amabile N., Tedgui A. Circulating microparticles-a potential prognostic marker for atherosclerotic vascular disease. Hypertension 2006, 48:180-186.
71. Michelsen A.E., Brodin E., Brosstad F., Hansen J.B. Increased level of platelet microparticles in survivors of myocardial infarction. Scand J Clin Lab Invest 2008, 68:386-392.
72. Morel O., Jesel L., Abbas M., Morel N. Prothrombotic changes in diabetes mellitus. Semin Thromb Hemost 2013, 39:477-488.
73. Kuriyama N., Nagakane Y., Hosomi A., Ohara T., Kasai T., Harada S., et al. Evaluation of factors associated with elevated levels of platelet-derived microparticles in the acute phase of cerebral infarction. Clin Appl Thromb Hemost 2010, 16:26-32.
74. Jung C., Sorensson P., Saleh N., Arheden H., Ryden L., Pernow J. Circulating endothelial and platelet derived microparticles reflect the size of myocardium at risk in patients with ST-elevation myocardial infarction. Atherosclerosis 2012, 221:226-231.
75. Vasina E., Heemskerk J.W.M., Weber C., Koenen R.R. Platelets and platelet-derived microparticles in vascular inflammatory disease. Inflamm Allergy Drug Targets 2010, 9:346-354.
76. Massberg S., Brand K., Gruner S., Page S., Muller E., Muller I., et al. A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med 2002, 196:887-896.
77. Huo Y., Schober A., Forlow S.B., Smith D.F., Hyman M.C., Jung S., et al. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med 2003, 9:61-67.
78. Tan K.T., Lip G.Y. The potential role of platelet microparticles in atherosclerosis. Thromb Haemost 2005, 94:488-492.
79. Merten M., Pakala R., Thiagarajan P., Benedict C.R. Platelet microparticles promote platelet interaction with subendothelial matrix in a glycoprotein IIb/IIIa-dependent mechanism. Circulation 1999, 99:2577-2582.
80. Gawaz M., Neumann F.J., Dickfeld T., Reininger A., Adelsberger H., Gebhardt A., et al. Vitronectin receptor (alpha(v)beta3) mediates platelet adhesion to the luminal aspect of endothelial cells: implications for reperfusion in acute myocardial infarction. Circulation 1997, 96:1809-1818.
81. Salonen E.M., Vaheri A., Pollanen J., Stephens R., Andreasen P., Mayer M., et al. Interaction of plasminogen activator inhibitor (PAI-1) with vitronectin. J Biol Chem 1989, 264:6339-6343.
82. Tan K.T., Lip G.Y. Platelets, atherosclerosis and the endothelium: new therapeutic targets?. Expert Opin Investig Drugs 2003, 12:1765-1776.
83. Barry O.P., Pratico D., Savani R.C., FitzGerald G.A. Modulation of monocyte-endothelial cell interactions by platelet microparticles. J Clin Invest 1998, 102:136-144.
84. Burger P.C., Wagner D.D. Platelet P-selectin facilitates atherosclerotic lesion development. Blood 2003, 101:2661-2666.
85. Forlow S.B., McEver R.P., Nollert M.U. Leukocyte-leukocyte interactions mediated by platelet microparticles under flow. Blood 2000, 95:1317-1323.
86. Setzer F., Oberle V., Blass M., Moller E., Russwurm S., Deigner H.P., et al. Platelet-derived microvesicles induce differential gene expression in monocytic cells: a DNA microarray study. Platelets 2006, 17:571-576.
87. Varki A. Trousseau's syndrome: multiple definitions and multiple mechanisms. Blood 2007, 110:1723-1729.
88. Gay L.J., Felding-Habermann B. Contribution of platelets to tumour metastasis. Nat Rev Cancer 2011, 11:123-134.
89. Goubran H.A., Burnouf T., Radosevic M., El-Ekiaby M. The platelet-cancer loop. Eur J Intern Med 2013, 24:393-400.
90. Goubran H.A., Stakiw J., Radosevic M., Burnouf T. Platelet-cancer interactions. Semin Thromb Hemost 2014, 40:296-305.
91. Gay L.J., Felding-Habermann B. Platelets alter tumor cell attributes to propel metastasis: programming in transit. Cancer Cell 2011, 20:553-554.
92. Labelle M., Begum S., Hynes R.O. Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell 2011, 20:576-590.
93. Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 2004, 25:581-611.
94. Cross M.J., Claesson-Welsh L. FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition. Trends Pharmacol Sci 2001, 22:201-207.
95. Falanga A., Tartari C.J., Marchetti M. Microparticles in tumor progression. Thromb Res 2012, 129(Suppl. 1):S132-S136.
96. Nurden A.T. Platelets, inflammation and tissue regeneration. Thromb Haemost 2011, 105(Suppl. 1):S13-S33.
97. Rak J. Microparticles in cancer. Semin Thromb Hemost 2010, 36:888-906.
98. Aatonen M., Gronholm M., Siljander P.R. Platelet-derived microvesicles: multitalented participants in intercellular communication. Semin Thromb Hemost 2012, 38:102-113.
99. Campello E., Spiezia L., Radu C.M., Bulato C., Castelli M., Gavasso S., et al. Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism. Thromb Res 2011, 127:473-477.
100. Kim H.K., Song K.S., Chung J.H., Lee K.R., Lee S.N. Platelet microparticles induce angiogenesis in vitro. Br J Haematol 2004, 124:376-384.
101. Sinauridze E.I., Kireev D.A., Popenko N.Y., Pichugin A.V., Panteleev M.A., Krymskaya O.V., et al. Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets. Thromb Haemost 2007, 97:425-434.
102. Janowska-Wieczorek A., Wysoczynski M., Kijowski J., Marquez-Curtis L., Machalinski B., Ratajczak J., et al. Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer. Int J Cancer 2005, 113:752-760.
103. Toth B., Liebhardt S., Steinig K., Ditsch N., Rank A., Bauerfeind I., et al. Platelet-derived microparticles and coagulation activation in breast cancer patients. Thromb Haemost 2008, 100:663-669.
104. Varon D., Hayon Y., Dashevsky O., Shai E. Involvement of platelet derived microparticles in tumor metastasis and tissue regeneration. Thromb Res 2012, 130(Suppl. 1):S98-S99.
105. Ay C., Pabinger I. Predictive potential of haemostatic biomarkers for venous thromboembolism in cancer patients. Thromb Res 2012, 129(Suppl. 1):S6-S9.
106. Thaler J., Ay C., Weinstabl H., Dunkler D., Simanek R., Vormittag R., et al. Circulating procoagulant microparticles in cancer patients. Ann Hematol 2011, 90:447-453.
107. Kim H.K., Song K.S., Park Y.S., Kang Y.H., Lee Y.J., Lee K.R., et al. Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor. Eur J Cancer 2003, 39:184-191.
108. Rank A., Liebhardt S., Zwirner J., Burges A., Nieuwland R., Toth B. Circulating microparticles in patients with benign and malignant ovarian tumors. Anticancer Res 2012, 32:2009-2014.
109. Trappenburg M.C., van Schilfgaarde M., Bredewold E.O., van Aalderen M.C., Spronk H.M., Ten Cate H., et al. Elevated numbers and altered subsets of procoagulant microparticles in breast cancer patients using endocrine therapy. Thromb Res 2011, 127:363-369.
110. Haubold K., Rink M., Spath B., Friedrich M., Chun F.K., Marx G., et al. Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancer. Thromb Haemost 2009, 101:1147-1155.
111. Hron G., Kollars M., Weber H., Sagaster V., Quehenberger P., Eichinger S., et al. Tissue factor-positive microparticles: cellular origin and association with coagulation activation in patients with colorectal cancer. Thromb Haemost 2007, 97:119-123.
112. Ikeda M., Iwamoto S., Imamura H., Furukawa H., Kawasaki T. Increased platelet aggregation and production of platelet-derived microparticles after surgery for upper gastrointestinal malignancy. J Surg Res 2003, 115:174-183.
113. Nomura S., Yasunaga K. Influence of platelet-derived microparticles on coagulation in a lung cancer patient receiving chemotherapy. Chest 1993, 103:979-980.
114. Helley D., Banu E., Bouziane A., Banu A., Scotte F., Fischer A.M., et al. Platelet microparticles: a potential predictive factor of survival in hormone-refractory prostate cancer patients treated with docetaxel-based chemotherapy. Eur Urol 2009, 56:479-484.
115. Vasina E.M., Cauwenberghs S., Feijge M.A., Heemskerk J.W., Weber C., Koenen R.R. Microparticles from apoptotic platelets promote resident macrophage differentiation. Cell Death Dis 2011, 2:e211.
116. Biswas S.K., Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol 2010, 11:889-896.
117. Semple J.W. Immune pathophysiology of autoimmune thrombocytopenic purpura. Blood Rev 2002, 16:9-12.
118. Sewify E.M., Sayed D., Abdel Aal R.F., Ahmad H.M., Abdou M.A. Increased circulating red cell microparticles (RMP) and platelet microparticles (PMP) in immune thrombocytopenic purpura. Thromb Res 2013, 131:e59-e63.
119. Jy W., Horstman L.L., Arce M., Ahn Y.S. Clinical significance of platelet microparticles in autoimmune thrombocytopenias. J Lab Clin Med 1992, 119:334-345.
120. Tantawy A.A.G., Matter R.M., Hamed A.A., El Telbany M. Platelet mocroparticles in immune thrombocytopenic purpura in pediatrics. Pediatr Hematol Oncol 2010, 27:283-296.
121. Herring J.M., McMichael M.A., Smith S.A. Microparticles in health and disease. J Vet Intern Med 2013, 27:1020-1033.
122. Boilard E., Nigrovic P.A., Larabee K., Watts G.F., Coblyn J.S., Weinblatt M.E., et al. Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science 2010, 327:580-583.
123. Duarte D., Taveira-Gomes T., Sokhatska O., Palmares C., Costa R., Negrao R., et al. Increased circulating platelet microparticles as a potential biomarker in asthma. Allergy 2013, 68:1073-1075.
124. Delabranche X., Berger A., Boisrame-Helms J., Meziani F. Microparticles and infectious diseases. Med Mal Infect 2012, 42:335-343.
125. Mayne E., Funderburg N.T., Sieg S.F., Asaad R., Kalinowska M., Rodriguez B., et al. Increased platelet and microparticle activation in HIV infection: upregulation of P-selectin and tissue factor expression. JAIDS 2012, 59:340-346.
126. Campos F.M.F., Franklin B.S., Teixeira-Carvalho A., Filho A.L.S., de Paula S.C.O., Fontes C.J., et al. Augmented plasma microparticles during acute Plasmodium vivax infection. Malaria J 2010, 9.
127. Faille D., El-Assaad F., Alessi M.C., Fusai T., Combes V., Grau G.E. Platelet-endothelial cell interactions in cerebral malaria: the end of a cordial understanding. Thromb Haemost 2009, 102:1093-1102.
128. Hottz E.D., Lopes J.F., Freitas C., Valls-de-Souza R., Oliveira M.F., Bozza M.T., et al. Platelets mediate increased endothelium permeability in dengue through NLRP3-inflammasome activation. Blood 2013, 122:3405-3414.
129. Tseng J.C., Hua C.C., Jiang B.Y., Chen H.J., Liu Y.C., Yu C.T., et al. Elevated circulating platelet and endothelial microparticles in patients with lung cancer. J Thorac Oncol 2011, 6:S948-S949.
130. Kriebardis A., Antonelou M., Stamoulis K., Papassideri I. Cell-derived microparticles in stored blood products: innocent-bystanders or effective mediators of post-transfusion reactions?. Blood Transfus 2012, 10(Suppl. 2):s25-s38.
131. Bode A.P., Orton S.M., Frye M.J., Udis B.J. Vesiculation of platelets during in vitro aging. Blood 1991, 77:887-895.
132. Krailadsiri P., Seghatchian J. Are all leucodepleted platelet concentrates equivalent? Comparison of Cobe LRS Turbo, haemonetics MCS plus LD, and filtered pooled buffy-coat-derived platelets. Vox Sang 2000, 78:171-175.
133. Vamvakas E.C., Blajchman M.A. Transfusion-related immunomodulation (TRIM): an update. Blood Rev 2007, 21:327-348.
134. Rank A., Nieuwland R., Liebhardt S., Iberer M., Gruetzner S., Toth B., et al. Apheresis platelet concentrates contain platelet-derived and endothelial cell-derived microparticles. Vox Sang 2011, 100:179-186.
135. Devine D.V., Bradley A.J., Maurer E., Levin E., Chahal S., Serrano K., et al. Effects of prestorage white cell reduction on platelet aggregate formation and the activation state of platelets and plasma enzyme systems. Transfusion 1999, 39:724-734.
136. Sugawara A., Nollet K.E., Yajima K., Saito S., Ohto H. Preventing platelet-derived microparticle formation-and possible side effects-with prestorage leukofiltration of whole blood. Arch Pathol Lab Med 2010, 134:771-775.
137. Lawrie A.S., Cardigan R.A., Williamson L.M., Machin S.J., Mackie I.J. The dynamics of clot formation in fresh-frozen plasma. Vox Sang 2008, 94:306-314.
138. George J.N., Pickett E.B., Heinz R. Platelet membrane microparticles in blood bank fresh frozen plasma and cryoprecipitate. Blood 1986, 68:307-309.
139. Strasser E.F., Happ S., Weiss D.R., Pfeiffer A., Zimmermann R., Eckstein R. Microparticle detection in platelet products by three different methods. Transfusion 2013, 53:156-166.
140. Khorana A.A., Francis C.W., Blumberg N., Culakova E., Refaai M.A., Lyman G.H. Blood transfusions, thrombosis, and mortality in hospitalized patients with cancer. Arch Intern Med 2008, 168:2377-2381.
141. Rank A., Nieuwland R., Crispin A., Grutzner S., Iberer M., Toth B., et al. Clearance of platelet microparticles in vivo. Platelets 2011, 22:111-116.
142. Kitazawa J., Nollet K., Morioka H., Tanaka K., Inomata M., Kubuki Y., et al. Non-D Rh antibodies appearing after apheresis platelet transfusion: stimulation by red cells or microparticles?. Vox Sang 2011, 100:395-400.
143. Burnouf T., Goubran H.A., Chen T.M., Ou K.L., El-Ekiaby M., Radosevic M. Blood-derived biomaterials and platelet growth factors in regenerative medicine. Blood Rev 2013, 27:77-89.
144. Nurden A.T., Nurden P., Sanchez M., Andia I., Anitua E. Platelets and wound healing. Front Biosci 2008, 13:3532-3548.
145. Tzeng Y.S., Deng S.C., Wang C.H., Tsai J.C., Chen T.M., Burnouf T. Treatment of nonhealing diabetic lower extremity ulcers with skin graft and autologous platelet gel: a case series. Biomed Res Int 2013, 2013:837620.
146. Chen T.M., Tsai J.C., Burnouf T. A novel technique combining platelet gel, skin graft, and fibrin glue for healing recalcitrant lower extremity ulcers. Dermatol Surg 2010, 36:453-460.
147. Mause S.F., Ritzel E., Liehn E.A., Hristov M., Bidzhekov K., Muller-Newen G., et al. Platelet microparticles enhance the vasoregenerative potential of angiogenic early outgrowth cells after vascular injury. Circulation 2010, 122:495-506.
148. Prokopi M., Pula G., Mayr U., Devue C., Gallagher J., Xiao Q., et al. Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures. Blood 2009, 114:723-732.
149. Ohtsuka M., Sasaki K.I., Ueno T., Seki R., Nakayoshi T., Koiwaya H., et al. Platelet-derived microparticles augment the adhesion and neovascularization capacities of circulating angiogenic cells obtained from atherosclerotic patients. Atherosclerosis 2013, 227:275-282.
150. Gruber R., Varga F., Fischer M.B., Watzek G. Platelets stimulate proliferation of bone cells: involvement of platelet-derived growth factor, microparticles and membranes. Clin Oral Implants Res 2002, 13:529-535.
151. Hayon Y., Dashevsky O., Shai E., Varon D., Leker R.R. Platelet microparticles promote neural stem cell proliferation, survival and differentiation. J Mol Neurosci 2012, 47:659-665.
152. Faille D., Combes V., Mitchell A.J., Fontaine A., Juhan-Vague I., Alessi M.C., et al. Platelet microparticles: a new player in malaria parasite cytoadherence to human brain endothelium. FASEB J 2009, 23:3449-3458.
153. Faille D., El-Assaad F., Mitchell A.J., Alessi M.C., Chimini G., Fusai T., et al. Endocytosis and intracellular processing of platelet microparticles by brain endothelial cells. J Cell Mol Med 2012, 16:1731-1738.
154. Brill A., Dashevsky O., Rivo J., Gozal Y., Varon D. Platelet-derived microparticles induce angiogenesis and stimulate post-ischemic revascularization. Cardiovasc Res 2005, 67:30-38.
155. Mack M., Kleinschmidt A., Bruhl H., Klier C., Nelson P.J., Cihak J., et al. Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: a mechanism for cellular human immunodeficiency virus 1 infection. Nat Med 2000, 6:769-775.
156. Hayon Y., Dashevsky O., Shai E., Brill A., Varon D., Leker R.R. Platelet microparticles induce angiogenesis and neurogenesis after cerebral ischemia. Curr Neurovasc Res 2012, 9:185-192.
157. Shan L.Y., Li J.Z., Zu L.Y., Niu C.G., Ferro A., Zhang Y.D., et al. Platelet-derived microparticles are implicated in remote ischemia conditioning in a rat model of cerebral infarction. CNS Neurosci Ther 2013, 19:917-925.